| gene silencing by mirna | GO:0035195 | 10 | 0.976 | |
| gene silencing by rna | GO:0031047 | 19 | 0.299 | |
| regionalization | GO:0003002 | 337 | 0.261 | |
| chromatin organization | GO:0006325 | 206 | 0.184 | |
| regulation of response to drug | GO:2001023 | 2 | 0.171 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.171 | |
| protein dna complex disassembly | GO:0032986 | 1 | 0.169 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.154 | |
| histone acetylation | GO:0016573 | 41 | 0.151 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.137 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.133 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.122 | |
| gene silencing | GO:0016458 | 38 | 0.120 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.119 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.112 | |
| protein acylation | GO:0043543 | 64 | 0.101 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.101 | Human |
| peptidyl lysine modification | GO:0018205 | 77 | 0.099 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.093 | Human |
| dna metabolic process | GO:0006259 | 303 | 0.093 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.092 | |
| histone lysine methylation | GO:0034968 | 50 | 0.091 | |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 5 | 0.088 | Human |
| regulation of histone methylation | GO:0031060 | 30 | 0.086 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.083 | |
| germ cell development | GO:0007281 | 185 | 0.081 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.080 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.075 | |
| male gamete generation | GO:0048232 | 285 | 0.075 | |
| rna interference | GO:0016246 | 2 | 0.073 | |
| stem cell development | GO:0048864 | 219 | 0.069 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.068 | Human |
| habituation | GO:0046959 | 3 | 0.068 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.068 | |
| placenta development | GO:0001890 | 140 | 0.067 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.066 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.065 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.063 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.058 | |
| histone methylation | GO:0016571 | 71 | 0.056 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.055 | Human |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.055 | Human |
| protein alkylation | GO:0008213 | 81 | 0.055 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.052 | Human |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.052 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.051 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.049 | |
| compound eye development | GO:0048749 | 1 | 0.049 | |
| regulation of cellular response to drug | GO:2001038 | 1 | 0.048 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.047 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.047 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.047 | |
| spermatid differentiation | GO:0048515 | 115 | 0.046 | |
| chemotaxis | GO:0006935 | 247 | 0.045 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.045 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.044 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.044 | |
| nucleosome disassembly | GO:0006337 | 1 | 0.043 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.042 | |
| response to sterol | GO:0036314 | 4 | 0.041 | |
| stem cell differentiation | GO:0048863 | 268 | 0.041 | |
| rna phosphodiester bond hydrolysis endonucleolytic | GO:0090502 | 10 | 0.040 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.040 | |
| embryonic placenta development | GO:0001892 | 98 | 0.040 | |
| olfactory learning | GO:0008355 | 2 | 0.040 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.040 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.040 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.039 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.039 | |
| chromatin modification | GO:0016568 | 187 | 0.039 | |
| rna processing | GO:0006396 | 105 | 0.038 | Human |
| mrna metabolic process | GO:0016071 | 84 | 0.038 | Human |
| regulation of histone modification | GO:0031056 | 56 | 0.037 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.037 | |
| regulation of translation ncrna mediated | GO:0045974 | 2 | 0.036 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.035 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.034 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.034 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.033 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.033 | |
| regulation of translation | GO:0006417 | 71 | 0.033 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.033 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.033 | |
| dna modification | GO:0006304 | 50 | 0.033 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.032 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.031 | |
| neuron projection guidance | GO:0097485 | 141 | 0.031 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.031 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.030 | |
| endoderm formation | GO:0001706 | 20 | 0.030 | |
| spermatogenesis | GO:0007283 | 284 | 0.030 | |
| multicellular organism growth | GO:0035264 | 161 | 0.030 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.030 | |
| translation | GO:0006412 | 93 | 0.030 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.030 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.029 | |
| dna methylation | GO:0006306 | 43 | 0.029 | |
| axonogenesis | GO:0007409 | 274 | 0.028 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.028 | |
| histone modification | GO:0016570 | 159 | 0.028 | |
| epithalamus development | GO:0021538 | 2 | 0.028 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.028 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.028 | |
| calcium mediated signaling using intracellular calcium source | GO:0035584 | 3 | 0.028 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| endoderm development | GO:0007492 | 45 | 0.027 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.027 | Human |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.026 | Human |
| microtubule based process | GO:0007017 | 236 | 0.026 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.026 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.025 | Human |
| rhythmic process | GO:0048511 | 174 | 0.025 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.025 | |
| maintenance of location | GO:0051235 | 89 | 0.025 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.025 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.025 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.025 | |
| methylation | GO:0032259 | 134 | 0.025 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.024 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.024 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.024 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.024 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.024 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.024 | Mouse |
| cilium morphogenesis | GO:0060271 | 102 | 0.024 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.024 | |
| digestive system development | GO:0055123 | 200 | 0.024 | |
| female sex differentiation | GO:0046660 | 84 | 0.024 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.023 | |
| sensory perception of sound | GO:0007605 | 97 | 0.023 | |
| dna alkylation | GO:0006305 | 43 | 0.023 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.023 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.023 | Human |
| amine metabolic process | GO:0009308 | 45 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| respiratory tube development | GO:0030323 | 167 | 0.022 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.022 | |
| defense response to other organism | GO:0098542 | 197 | 0.022 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.022 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.022 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.022 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.022 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.022 | Human |
| molting cycle | GO:0042303 | 90 | 0.022 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.022 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.022 | |
| segmentation | GO:0035282 | 93 | 0.021 | |
| rna 3 end processing | GO:0031123 | 20 | 0.021 | Human |
| response to nutrient levels | GO:0031667 | 109 | 0.021 | Mouse |
| regulation of defense response | GO:0031347 | 233 | 0.021 | |
| lipid localization | GO:0010876 | 126 | 0.021 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.021 | |
| negative regulation of translation | GO:0017148 | 22 | 0.021 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.021 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.021 | |
| stem cell maintenance | GO:0019827 | 130 | 0.021 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.020 | |
| production of small rna involved in gene silencing by rna | GO:0070918 | 6 | 0.020 | |
| cognition | GO:0050890 | 149 | 0.020 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.020 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.020 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.020 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | Human |
| regulation of cellular component size | GO:0032535 | 121 | 0.019 | |
| organelle assembly | GO:0070925 | 177 | 0.019 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.019 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.019 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.019 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.019 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.019 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.019 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.019 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.019 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.019 | |
| neural tube closure | GO:0001843 | 90 | 0.019 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.019 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.019 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.018 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.018 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.018 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.018 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.018 | |
| forebrain development | GO:0030900 | 302 | 0.018 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.018 | |
| protein complex disassembly | GO:0043241 | 40 | 0.018 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.018 | |
| mrna catabolic process | GO:0006402 | 22 | 0.018 | Human |
| organophosphate catabolic process | GO:0046434 | 232 | 0.018 | |
| mrna processing | GO:0006397 | 63 | 0.018 | Human |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.018 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.017 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.017 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.017 | |
| somitogenesis | GO:0001756 | 69 | 0.017 | |
| telencephalon development | GO:0021537 | 186 | 0.017 | |
| muscle tissue development | GO:0060537 | 308 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.017 | |
| positive regulation of notch signaling pathway | GO:0045747 | 18 | 0.017 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.017 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.017 | |
| notch signaling pathway | GO:0007219 | 71 | 0.017 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.017 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.017 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.017 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.017 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.016 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.016 | |
| chromatin remodeling | GO:0006338 | 32 | 0.016 | |
| lateral inhibition | GO:0046331 | 1 | 0.016 | |
| learning | GO:0007612 | 98 | 0.016 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| positive regulation of mrna 3 end processing | GO:0031442 | 5 | 0.016 | Human |
| cellular amine metabolic process | GO:0044106 | 44 | 0.016 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.016 | |
| lipid storage | GO:0019915 | 36 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.016 | |
| learning or memory | GO:0007611 | 148 | 0.015 | |
| innate immune response | GO:0045087 | 157 | 0.015 | |
| chromatin disassembly | GO:0031498 | 1 | 0.015 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.015 | |
| gland development | GO:0048732 | 330 | 0.015 | |
| axon guidance | GO:0007411 | 141 | 0.015 | |
| positive regulation of mrna processing | GO:0050685 | 16 | 0.015 | Human |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.015 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.015 | |
| oogenesis | GO:0048477 | 56 | 0.015 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.015 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.015 | |
| protein targeting | GO:0006605 | 143 | 0.015 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.015 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| female gamete generation | GO:0007292 | 74 | 0.015 | |
| cellular response to drug | GO:0035690 | 15 | 0.015 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | |
| lung development | GO:0030324 | 164 | 0.014 | |
| mirna metabolic process | GO:0010586 | 10 | 0.014 | |
| macromolecule methylation | GO:0043414 | 120 | 0.014 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.014 | |
| nuclear transport | GO:0051169 | 139 | 0.014 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.014 | |
| blastocyst growth | GO:0001832 | 23 | 0.014 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.014 | |
| female gonad development | GO:0008585 | 71 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.014 | |
| gonad development | GO:0008406 | 141 | 0.014 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| response to starvation | GO:0042594 | 65 | 0.014 | Mouse |
| hypermethylation of cpg island | GO:0044027 | 3 | 0.014 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.013 | |
| dendrite development | GO:0016358 | 115 | 0.013 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.013 | |
| cell growth | GO:0016049 | 130 | 0.013 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.013 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.013 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.013 | |
| amide transport | GO:0042886 | 138 | 0.013 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.013 | |
| protein methylation | GO:0006479 | 81 | 0.013 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.013 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.013 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| ovulation cycle | GO:0042698 | 59 | 0.012 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.012 | |
| male gonad development | GO:0008584 | 88 | 0.012 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.012 | |
| regulation of transcription from rna polymerase ii promoter by galactose | GO:0000431 | 1 | 0.012 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.012 | |
| pre mirna processing | GO:0031054 | 3 | 0.012 | |
| ovarian follicle development | GO:0001541 | 40 | 0.012 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.012 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.012 | |
| gastrulation | GO:0007369 | 116 | 0.012 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.012 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.012 | Human |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.012 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.012 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.012 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.012 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.012 | |
| epithelial cell development | GO:0002064 | 159 | 0.012 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.012 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.012 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.012 | |
| atp metabolic process | GO:0046034 | 75 | 0.012 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.012 | |
| endocytosis | GO:0006897 | 168 | 0.012 | |
| n terminal protein amino acid modification | GO:0031365 | 6 | 0.011 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.011 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.011 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.011 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.011 | |
| response to uv | GO:0009411 | 44 | 0.011 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.011 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.011 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.011 | |
| blastocyst development | GO:0001824 | 80 | 0.011 | |
| spleen development | GO:0048536 | 39 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.011 | |
| protein catabolic process | GO:0030163 | 221 | 0.011 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.011 | |
| oxidation reduction process | GO:0055114 | 342 | 0.011 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.011 | |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.011 | |
| ectoderm formation | GO:0001705 | 3 | 0.011 | |
| immune effector process | GO:0002252 | 321 | 0.011 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.011 | |
| germ line stem cell maintenance | GO:0030718 | 6 | 0.011 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.011 | |
| muscle contraction | GO:0006936 | 101 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.011 | |
| skeletal system development | GO:0001501 | 356 | 0.011 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.011 | |
| myotube differentiation | GO:0014902 | 105 | 0.011 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.011 | |
| microtubule based movement | GO:0007018 | 84 | 0.010 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.010 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.010 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.010 | |
| negative regulation of translational initiation | GO:0045947 | 4 | 0.010 | |
| habenula development | GO:0021986 | 2 | 0.010 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.010 | |
| regulation of lymphocyte anergy | GO:0002911 | 4 | 0.010 | |
| somite development | GO:0061053 | 81 | 0.010 | |
| positive regulation of growth | GO:0045927 | 104 | 0.010 | |
| rna phosphodiester bond hydrolysis | GO:0090501 | 19 | 0.010 | |
| feeding behavior | GO:0007631 | 62 | 0.010 | |
| neural tube formation | GO:0001841 | 108 | 0.010 | |
| tube formation | GO:0035148 | 140 | 0.010 | |
